ResearcherNihon UniversityActive in the last 2 years
Takahiro Suzuki
Matched on ORCID iD 0000-0002-0591-3445; OpenAlex author ID A5064648343. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 10
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 5
- Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. Last author DOI 10.1016/j.biopha.2025.118098↗
- Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. Last author DOI 10.1136/rapm-2023-104511↗
- Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. Last author DOI 10.1097/j.pain.0000000000002852↗
- Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.bja.2021.12.042↗
- Duloxetine improves cancer-associated pain in a mouse model of pancreatic cancer through stimulation of noradrenaline pathway and its antitumor effects. Last author DOI 10.1097/j.pain.0000000000001997↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Makoto Sano · 5 shared papers, 2020–2025 · strength 0.85
- Paper Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. DOI 10.1016/j.biopha.2025.118098↗
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Yukino Oshima · 5 shared papers, 2020–2025 · strength 0.85
- Paper Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. DOI 10.1016/j.biopha.2025.118098↗
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Hideaki Ijichi · 5 shared papers, 2020–2025 · strength 0.85
- Paper Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. DOI 10.1016/j.biopha.2025.118098↗
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Tomoaki Itaya · 4 shared papers, 2022–2025 · strength 0.75
- Paper Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. DOI 10.1016/j.biopha.2025.118098↗
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Tomoya Kuramochi · 4 shared papers, 2022–2025 · strength 0.75
- Paper Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. DOI 10.1016/j.biopha.2025.118098↗
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Ichie Kajiwara · 4 shared papers, 2020–2024 · strength 0.61
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Paper Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. DOI 10.1016/j.bja.2021.12.042↗
- Yoshimi Ichimaru · 4 shared papers, 2020–2024 · strength 0.61
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Paper Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. DOI 10.1016/j.bja.2021.12.042↗
- Atsushi Masamune · 4 shared papers, 2020–2024 · strength 0.61
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Paper Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. DOI 10.1016/j.bja.2021.12.042↗
- Yohei Masugi · 1 shared paper, 2022 · strength 0.13
- Hiroyuki Hao · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.